Pharmacogenomics of angiotensin converting enzyme inhibitors in renal disease – pathophysiological considerations

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.4, Iss.2, 2003-03, pp. : 153-162

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Ongoing trials involving angiotensin-converting enzyme inhibitors

By Nadar Sunil Lip Gregory YH

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 11, 2002-11 ,pp. : 1633-1643

Informa Healthcare

Access to resources Recommend Favorite

Chemistry and Pharmacology of Angiotensin-Converting Enzyme Inhibitors

Current Pharmaceutical Design, Vol. 21, Iss. 13, 2015-04 ,pp. : 1764-1775

Bentham Science Publishers

Access to resources Recommend Favorite

Dipeptide Inhibitors of Thermolysin and Angiotensin I-Converting Enzyme

Current Topics in Medicinal Chemistry, Vol. 12, Iss. 16, 2012-08 ,pp. : 1748-1762

Bentham Science Publishers

Access to resources Recommend Favorite

The Application of Angiotensin Converting Enzyme Inhibitors in Heart Surgery

Letters in Drug Design & Discovery, Vol. 2, Iss. 2, 2005-03 ,pp. : 105-108

Bentham Science Publishers

Access to resources Recommend Favorite

Effect of Angiotensin Converting Enzyme Inhibitors on Ischaemia-Reperfusion-Induced Renal Injury in Rats

By Krishan P. Sharma A. Singh M.

Pharmacological Research, Vol. 37, Iss. 1, 1998-01 ,pp. : 23-29

Academic Press

Access to resources Recommend Favorite